Many Young South African Women, U.S. MSM, Thai Transgender Women In Study Adhere To Daily PrEP Regimen

New York Times: Daily HIV Drug Regimen Is Effective in African Women, Study Says
“…The study, called ADAPT, found that wide majorities of young women in Cape Town, South Africa — as well as [transgender women] in Bangkok and younger gay men in Harlem — were willing and able to take the [antiretroviral] pills daily. Previous studies have shown that taking the drug, called Truvada, faithfully every day provides nearly perfect protection against HIV, even in people having regular unsafe sex…” (McNeil, 7/22).

NIH: Young South African women can adhere to daily PrEP regimen as HIV prevention
“…Although some previous placebo-controlled PrEP clinical trials in women in sub-Saharan Africa had found challenges with adherence, 76 percent of women assigned to take PrEP on a daily basis in the HIV Prevention Trials Network (HPTN) 067 study adhered to the prescribed regimen. MSM and [transgender women (TGW)] from Harlem and Bangkok who participated in the study adhered to the daily regimen 65 percent and 85 percent of the time, respectively…” (7/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.